Nimesulide and indomethacin induce apoptosis in head and neck cancer cells
Martina Pelzmann1, Dietmar Thurnher, Claudia Gedlicka
1Department of Otorhinolaryngology, University of Vienna, Währinger Gürtel, Vienna, Austria. martina.pelzmann@aon.at
Background:
Non-steroidal anti-inflammatory drugs (NSAIDs) are known to inhibit the enzyme cyclooxygenase (COX). There are two isoforms of the enzyme. Recent investigations indicate that both isoforms, COX-1 and COX-2, are involved in carcinogenesis.
Methods:
We investigated the effects of nimesulide, a COX-2 selective and indomethacin, a non-selective NSAID on the head and neck squamous cell carcinoma (HNSCC) cell lines SCC-9 and SCC-25. Effects on cell numbers and apoptosis were assayed by cell counting, immunofluorescence and fluorescence activated cell sorting (FACS). COX expression was examined by Western blotting.
Results:
The investigated cell lines express COX-1 and COX-2. Nimesulide and indomethacin induce apoptosis and cause a reduction of cell number. Incubation with NSAIDs upregulated COX-2 expression.
Conclusion:
The results of our study on HNSCC cells together with data from different studies showing anti-cancer activity of NSAIDs suggest that COX inhibitors could play a role in HNSCC treatment and prevention.
Insights
Non-steroidal anti-inflammatory drugs (NSAIDs) targeting cyclooxygenase-2 (COX-2) show potential in treating head and neck squamous cell carcinoma (HNSCC). These drugs induce cancer cell death and reduce cell numbers, suggesting a role in HNSCC therapy.
Area of Science:
- Oncology
- Pharmacology
Background:
- Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit cyclooxygenase (COX) enzymes.
- Both COX-1 and COX-2 isoforms are implicated in cancer development.
- Head and Neck Squamous Cell Carcinoma (HNSCC) is a significant area of oncological research.
Purpose of the Study:
- To investigate the effects of COX-2 selective (nimesulide) and non-selective (indomethacin) NSAIDs on HNSCC cell lines.
- To assess the impact of these NSAIDs on cancer cell proliferation and apoptosis.
- To examine the expression levels of COX enzymes in HNSCC cells under NSAID treatment.
Main Methods:
- Utilized HNSCC cell lines SCC-9 and SCC-25.
- Assayed cell numbers and apoptosis using cell counting, immunofluorescence, and fluorescence-activated cell sorting (FACS).
- Analyzed cyclooxygenase (COX) expression via Western blotting.
Main Results:
- Both investigated HNSCC cell lines express COX-1 and COX-2.
- Nimesulide and indomethacin treatment led to increased apoptosis and reduced cell numbers.
- NSAID incubation resulted in the upregulation of COX-2 expression.
Conclusions:
- NSAIDs, particularly COX inhibitors, demonstrate anti-cancer activity in HNSCC cell lines.
- These findings suggest a potential therapeutic role for COX inhibitors in the treatment and prevention of HNSCC.
- Further research into NSAIDs for HNSCC management is warranted based on observed anti-cancer effects.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The Extrinsic Apoptotic Pathway
Inhibition of Cdk Activity

